Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients
- PMID: 38597981
- DOI: 10.1007/s00296-024-05576-7
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients
Abstract
Global health (GH) and health-related quality of life are patient priorities in axial spondyloarthritis (axSpA). Our objective was to assess the relative importance of disease-related factors including disease activity, and patient-related factors including comorbidities, to explain GH in axSpA. Post hoc cross-sectional analyses of 4 sets (COMOSPA, PERSPA, COMEDSPA, and DESIR) of patients fulfilling ASAS criteria for axSpA. GH was assessed through the ASAS Health Index (ASAS-HI) or the EuroQoL-5D-3L (EQ-5D). Disease-related factors included disease activity (ASDAS, psoriasis, arthritis, enthesitis, and CRP), disease duration, diagnostic delay, bamboo spine, and treatment. Non-disease-related factors included sociodemographic characteristics, comorbidities and chronic widespread pain. Multivariable logistic and linear regressions and partial variances (R2) were applied to identify independent determinants of GH. In 6064 patients (range 284-2756 across datasets), mean age ranged 38.9-45.8 years, 51-68% were male. GH was generally moderate: median ASAS-HI ranged 5.0-7.0. GH was explained by ASDAS (range of odds ratios, OR, 2.60-4.48) and chronic widespread pain (range of OR 2.19-8.39); other determinants included comorbidities and sociodemographic characteristics. Only 47-57% of the total variance in GH could be explained by the models; disease activity (partial variance, 16-26%) and chronic widespread pain (partial variance 12-15%) were the key contributing variables. A wide range of disease and non-disease-related variables usually collected in studies could only explain 47-57% of the variability in GH. Among these, disease activity and chronic widespread pain were most relevant and of similar magnitude of importance. These findings will be helpful for shared decision-making.
Keywords: Axial spondyloarthritis; Fibromyalgia; Inflammation; Patient reported outcome measures.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Global health in axial spondyloarthritis: thresholds for the Assessment of SpondyloArthritis international Society Health Index and the EuroQol score: analysis of the ASAS-PerSpA study.Scand J Rheumatol. 2025 May;54(3):175-183. doi: 10.1080/03009742.2024.2424085. Epub 2024 Dec 16. Scand J Rheumatol. 2025. PMID: 39679471
-
Determinants of health-related quality of life and global functioning and health in axSpA, pSpA and PsA: results from the ASAS-PerSpA study.Rheumatology (Oxford). 2024 Jul 1;63(7):1938-1948. doi: 10.1093/rheumatology/kead503. Rheumatology (Oxford). 2024. PMID: 37738594
-
Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.Health Qual Life Outcomes. 2016 May 17;14:78. doi: 10.1186/s12955-016-0463-1. Health Qual Life Outcomes. 2016. PMID: 27188166 Free PMC article.
-
How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice.Curr Rheumatol Rep. 2024 May;26(5):170-177. doi: 10.1007/s11926-024-01141-0. Epub 2024 Feb 19. Curr Rheumatol Rep. 2024. PMID: 38372873 Review.
-
Optimisation of rheumatology assessments - the actual situation in axial spondyloarthritis including ankylosing spondylitis.Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-96-104. Epub 2014 Oct 30. Clin Exp Rheumatol. 2014. PMID: 25365096 Review.
Cited by
-
Difficult-to-Treat Axial Spondyloarthritis: A New Challenge.Drugs. 2024 Dec;84(12):1501-1508. doi: 10.1007/s40265-024-02100-w. Epub 2024 Oct 10. Drugs. 2024. PMID: 39388075 Review.
-
Changes in health related quality of life in mothers with inflammatory joint disease from year 2000 to 2020 - a comparative cross-sectional study.Front Glob Womens Health. 2025 Jan 8;5:1458390. doi: 10.3389/fgwh.2024.1458390. eCollection 2024. Front Glob Womens Health. 2025. PMID: 39845311 Free PMC article.
References
-
- Kiltz U, Essers I, Hiligsmann M, Braun J, Maksymowych WP, Taylor WJ, van der Heijde D, Boonen A (2016) Which aspects of health are most important for patients with spondyloarthritis? A Best Worst Scaling based on the ASAS Health Index. Rheumatology (Oxford) 55(10):1771–1776. https://doi.org/10.1093/rheumatology/kew238 - DOI - PubMed
-
- Navarro-Compán V, Sepriano A, El-Zorkany B, van der Heijde D (2021) Axial spondyloarthritis. Ann Rheum Dis 80(12):1511–1521. https://doi.org/10.1136/annrheumdis-2021-221035 - DOI - PubMed
-
- Puyraimond-Zemmour D, Granger B, Molto A, Gaujoux-Viala C, Guillemin F, Ruyssen-Witrand A, Dougados M, Fautrel B, Gossec L (2019) Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain. Arthritis Res Ther 21(1):63. https://doi.org/10.1186/s13075-019-1841-y - DOI - PubMed - PMC
-
- Dean LE, Macfarlane GJ, Jones GT (2018) Five potentially modifiable factors predict poor quality of life in ankylosing spondylitis: results from the Scotland registry for ankylosing spondylitis. J Rheumatol 45(1):62–69. https://doi.org/10.3899/jrheum.160411 - DOI - PubMed
-
- Elolemy G, Aboughanima A, Ganeb S, Elziat H (2020) Health-related quality of life in patients with ankylosing spondylitis: relationship with disease-related variables. Curr Rheumatol Rev 16(4):311–318. https://doi.org/10.2174/1573397115666191018162606 - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous